» Articles » PMID: 26571215

Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose Radiobiology

Overview
Journal Med Princ Pract
Publisher Karger
Date 2015 Nov 17
PMID 26571215
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Screening mammography offers the possibility of discovering malignant diseases at an early stage, which is consequently treated early, thereby reducing the mortality rate. However, ionizing radiation as used in low-dose X-ray mammography may be associated with a risk of radiation-induced carcinogenesis. In the context of the harmful effects of ionizing radiation, this article reviewed novel radiobiological data and provided a simulation of the relative incidence of radiation-induced breast cancer due to screening against a background baseline incidence in a population of 100,000 individuals. The use of modern digital mammographic technology was assumed, giving rise to a glandular dose of 2.5 mGy from a 2-view per breast image. Assuming no latency time, this led to a ratio of induced incidence rate over baseline incidence rate of about 1.6‰ for biennial screening in women aged 50-74 years, although it cannot be excluded that the dose and dose rate effectiveness factor values relying on new radiobiological insights may lower this number to about 0.7‰. This carcinogenic risk is considered small in relation to the potential beneficial effects of screening, especially as latency time was not taken into consideration. However, individuals who are known to be carriers of risk-increasing genetic variations and/or have an inherited disposition of breast cancer should avoid ionizing radiation as much as possible and should be referred to ultrasound or magnetic resonance imaging. In addition, a significant, but difficult to quantify, risk of cancer is present for individuals who suffer from hypersusceptibility to ionizing radiation.

Citing Articles

Swarm learning with weak supervision enables automatic breast cancer detection in magnetic resonance imaging.

Saldanha O, Zhu J, Muller-Franzes G, Carrero Z, Payne N, Escudero Sanchez L Commun Med (Lond). 2025; 5(1):38.

PMID: 39915630 PMC: 11802753. DOI: 10.1038/s43856-024-00722-5.


LightweightUNet: Multimodal Deep Learning with GAN-Augmented Imaging Data for Efficient Breast Cancer Detection.

Rai H, Yoo J, Agarwal S, Agarwal N Bioengineering (Basel). 2025; 12(1).

PMID: 39851348 PMC: 11761908. DOI: 10.3390/bioengineering12010073.


U structured network with three encoding paths for breast tumor segmentation.

Zhang H, Ma Q, Chen Y Sci Rep. 2023; 13(1):21597.

PMID: 38062236 PMC: 10703786. DOI: 10.1038/s41598-023-48883-y.


ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.

Carton C, Evans D, Blanco I, Friedrich R, Ferner R, Farschtschi S EClinicalMedicine. 2023; 56:101818.

PMID: 36684394 PMC: 9845795. DOI: 10.1016/j.eclinm.2022.101818.


Relative biological effectiveness of low-energy X-rays (25 kV) in mutant p53 cancer cells.

Habelt B, Dorr W Radiat Environ Biophys. 2023; 62(1):161-170.

PMID: 36609923 PMC: 9950242. DOI: 10.1007/s00411-022-01014-z.


References
1.
Pauwels E, Bourguignon M . Radiation dose features and solid cancer induction in pediatric computed tomography. Med Princ Pract. 2012; 21(6):508-15. DOI: 10.1159/000337404. View

2.
Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D . Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med. 2008; 148(9):671-9. DOI: 10.7326/0003-4819-148-9-200805060-00007. View

3.
Brodersen J, Siersma V . Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med. 2013; 11(2):106-15. PMC: 3601385. DOI: 10.1370/afm.1466. View

4.
Davis J, Lin S . DNA damage and breast cancer. World J Clin Oncol. 2011; 2(9):329-38. PMC: 3168783. DOI: 10.5306/wjco.v2.i9.329. View

5.
de Gelder R, Draisma G, Heijnsdijk E, de Koning H . Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths. Br J Cancer. 2011; 104(7):1214-20. PMC: 3068504. DOI: 10.1038/bjc.2011.67. View